SLAMF7 and B-cell chronic lymphocytic leukemia: By flow cytometry analysis, pathological CLL B cells showed a decreased expression of SLAMF7/CD319 in comparison with normal B cells from healthy control subjects as well as when compared with normal polyclonal B cells present in CLL patient samples [36].